SpaceX in Canadian Index ETFs After the IPO

SpaceX priced its initial public offering at $135 per share and began trading on Nasdaq and Nasdaq Texas under the ticker SPCX on June 12, 2026. The base offering covered 555,555,555 new Class A shares for $75 billion. After the underwriters exercised their option in full, SpaceX closed the sale of 638,888,888 shares on June 15 and reported approximately $85.7 billion in gross proceeds.

For Canadian index investors, the important question is not whether SpaceX is exciting or overpriced. It is simpler: if you own a broad US or global ETF, when would your fund buy it, and how much would you actually own?

Update — July 14, 2026: Final IPO terms and closing figures now replace the pre-pricing estimates in the original June 3 article. Nasdaq announced that SPCX would join the Nasdaq-100 before market open on July 7, and that inclusion has now occurred. The CRSP, S&P Total Market, lockup, and S&P 500 dates below remain methodology-based projections unless a linked primary index notice or dated fund holding says otherwise.

TL;DR

• The final offering sold 638,888,888 shares after the option exercise. That still represents a small public float, so float-adjusted indexes would weight SPCX by a much smaller investable value than its full-company valuation.
• CRSP's changed rules created a path for a fast off-cycle addition to VUN and the US sleeve of VEQT/VXC. Without a primary inclusion notice or dated holding in this article, that timing remains a projection rather than a confirmed fund event.
• S&P's June 4 Total Market rule created a similar fast-track path for ITOT and the US sleeve used by XEQT/XUU. The eligibility analysis is confirmed; the precise fund purchase date is not asserted here without a dated holding.
• S&P left the S&P 500 rules unchanged, so VFV, XUS, ZSP, and ZUE will not pick up SpaceX until it clears the 10% float, 12-month seasoning, and profitability tests, which points to 2027 at the earliest and is not guaranteed.
• Nasdaq announced SPCX's Nasdaq-100 inclusion for July 7, 2026. Nasdaq-100 funds such as XQQ, QQC, ZNQ, and the US-listed QQQ therefore received benchmark exposure from that date, subject to each fund's implementation and tracking.
• The initial position is still small: the final IPO proceeds imply roughly $13 per $10,000 in broad US market exposure under the article's market-size assumptions, while Nasdaq-100 exposure depends on the index's special float-related cap and the stock price at the inclusion reference date.
• CAGE would likely hold little or none, because its Avantis factor process tilts toward value and profitability rather than buying every index addition.

Why this IPO is different

SpaceX is not an empty hype story. It reported $18.7 billion in 2025 revenue, Starlink is a real business with millions of subscribers, and the company dominates global launch by a wide margin. Anthropic filed for its own IPO on June 1, 2026, and OpenAI is widely expected to follow later in the year, so the market is treating this as a broader mega-IPO wave rather than a one-off.

The caution case is also real, and worth taking seriously before you cheer the addition. SpaceX is targeting a valuation more than double Morningstar’s reported fair-value estimate of about $780 billion, posted a nearly $5 billion net loss in 2025, and now includes xAI and X after a roughly $250 billion merger that explains much of that loss. Its reported Anthropic compute agreement, signed only weeks before the IPO, carries a 90-day termination right, which makes that headline revenue less durable than it first appears. None of this makes SpaceX a bad company. It makes the price a genuine open question, which is exactly why how it enters your portfolio matters.

The most important structural fact is the float. The final offering sold 638,888,888 shares, including the underwriters' option, while most pre-IPO shares remained restricted. That is tiny next to mature mega-caps like Microsoft, Nvidia, or Amazon, which float nearly all of their shares, and it means index inclusion competes for a limited pool of available stock.

Which ETFs could buy SpaceX first?

Historically, new public companies had to season for months before major indexes would add them. That buffer existed to let trading settle and prevent indexes from chasing IPO hype. Several index providers have now changed those rules specifically for mega-cap IPOs, which is what speeds up SpaceX’s path into some funds, though not all of them, and not all at the same time.

CRSP US Total Market: VUN, VTI, VEQT, VXC

This is the clearest path. CRSP amended its methodology in April 2026 so a new IPO can become eligible after just five trading days if it passes the eligibility and investability screens, and CRSP adds those large IPOs off-cycle rather than making them wait for the next quarterly reconstitution.

The old screen required at least 10% free float, which SpaceX’s roughly 4% post-offering float would have failed outright. The new alternative test allows entry with roughly $3.3 billion in float-adjusted market capitalization instead, a bar SpaceX clears many times over.

Because CRSP weights by free float rather than total market cap, the relevant starting value is closer to the approximately $85.7 billion sold in the completed offering than the value of the whole company. The exact index float can differ from shares sold, so this is an illustration, not a confirmed CRSP weight.

Projected timing under the methodology: about five trading days after listing. Verify against a dated VUN/VTI holding before treating the addition as confirmed.

S&P Total Market: XEQT, XUU, ITOT, XGRO, XBAL

The eligibility path is now confirmed, and fast. On June 4, 2026, S&P Dow Jones finalized its consultation and changed the S&P Total Market Index rules: a company is eligible if it has an Investable Weight Factor of at least 0.10 (a 10% float) or a float-adjusted market cap of at least 10% of the 100th largest company in the index. SpaceX fails the float test but clears the new market-cap test easily, so it qualifies under the rule effective June 8, 2026. This article does not claim a precise fund purchase date without a primary addition notice or dated holding.

Crucially, the same change gives the S&P Total Market Index, the S&P Completion Index, and the Dow Jones U.S. Total Stock Market Index an IPO fast-track: once S&P announces a qualifying IPO (assessed on the stock’s first-day closing price), it is added off-cycle with about five business days’ lead time, rather than waiting for the next quarterly rebalance. Because SpaceX meets the updated eligibility rule through the market-cap test, it is fast-track eligible. ITOT, the US-listed fund XEQT and XUU hold for their US exposure, tracks the index and so reflects that fast-track addition.

Projected timing for XEQT/XUU holders under the methodology: roughly a week after listing via the S&P Total Market fast-track. Verify against a dated ITOT/XUU holding for the actual implementation date.

Nasdaq-100: XQQ, QQC, ZNQ, QQQ

Nasdaq changed its rules effective May 1, 2026. A large IPO can enter the Nasdaq-100 after 15 trading days if its market cap ranks in the top 40 of index companies. On June 26, Nasdaq issued the primary notice: SPCX would become a Nasdaq-100 component before market open on July 7, 2026. That date has passed, so the index event is confirmed rather than projected.

Rather than screen out the tiny float, Nasdaq handles it with a weighting cap: a constituent’s weight is limited to the lesser of its full market cap or three times its float-adjusted market cap. At a 4.3% float, that cap binds hard, so SpaceX would count at roughly three times its float-adjusted value, about $230 billion, instead of the full $1.8 trillion. Because Nasdaq-100 funds hold a large pool of assets against that limited float, this is where the most concentrated forced buying is likely to land, and the cap loosens as the float grows later in the year.

Confirmed Nasdaq-100 index date: July 7, 2026. Fund-level execution and tracking can differ slightly from the benchmark event.

S&P 500: VFV, XUS, ZSP, ZUE

The S&P 500 is the slowest path, which surprises people, since it is the index most Canadians picture first. The June 4 consultation result settled this: S&P left the S&P 500 criteria unchanged, stating that exceptions to the financial viability, seasoning, and IWF requirements should not be granted solely based on market capitalization. So the proposed shorter seasoning window did not happen.

That leaves SpaceX facing the full set of hurdles. It needs a float of at least 10% (its IWF starts around 4.3% and only crosses 10% as the lockups release later in 2026), a 12-month seasoning period (which runs to roughly June 2027 given a June 12 listing), and positive GAAP earnings over the most recent quarter and the trailing four quarters together (SpaceX reported a large 2025 loss). Even once it clears all of that, the index committee still decides, weighing sector balance and other factors.

Likely timing for VFV holders: 2027 at the earliest, contingent on SpaceX turning profitable, and not guaranteed.

Russell indexes

FTSE Russell has also been working on fast-entry rules for IPOs, but Russell exposure is less common in Canadian ETF portfolios than CRSP, S&P, or Nasdaq exposure. If you own a Russell-tracking fund, check the fund’s specific index and reconstitution schedule, since inclusion would likely land at a scheduled reconstitution rather than on a fast track.

The lockup matters

SpaceX’s float is projected to rise from its small post-offering level. Most IPOs use a single 180-day lockup, but SpaceX disclosed a staged release that could open shares in steps through late 2026 and into 2027. These are future eligibility dates, not promises that every share will be sold:

• Musk’s roughly 42% stake is locked for a full 366 days with no early release, so it stays off the market until around mid-2027.
• Other large pre-IPO investors, the “extended” group, are mostly locked until 2027 as well, with only a first 20% tranche expected to release on December 31, 2026.
• The 180-day pool, roughly 4.7 billion shares, is the group that drives the 2026 float expansion. It unlocks in stages: after Q2 earnings, at the 70/90/105/120/135-day marks, after Q3 earnings, and finally in full at the 180-day mark in December.

This matters because index weights track free float, not total shares. As more shares become tradeable through the year, an index fund’s required SpaceX weight rises even if the share price never moves. The table below isolates that effect.

The projected percentages are based on the prospectus lockup buckets, not later trading or fund holdings. Actual index weights will also depend on the share price, the provider's investable-weight decision, corporate actions, and the size of the rest of the index.

How much would you own?

Using the approximately $85.7 billion of final gross offering proceeds as a rough investable-value proxy against a $64 trillion US total market gives an illustrative initial broad-market weight of about 0.13%, or roughly $13 per $10,000 of pure US total-market exposure. The provider's actual float factor can differ from this proxy.

These are rough first-day estimates, not targets. The all-in-one funds dilute the exposure because US equities are only part of the fund: VGRO holds a smaller US sleeve than VUN, and VBAL holds less equity overall, so each one’s SpaceX sliver is correspondingly thinner.

There is a counterintuitive lesson buried in this table. Total-market methodologies created a faster route than the S&P 500 rules. Whether a particular fund completed that purchase on the projected date should be checked in its dated holdings, while a focused S&P 500 fund still waits until a future committee addition, if one occurs.

And even the largest of these positions is unlikely to be portfolio-changing at first. The reason it is worth understanding is not one estimated dollar figure; it is the principle: “passive” index exposure still depends on rules that someone writes, and those rules changed specifically to admit unusually large companies with small public floats.

What about all-in-one funds like XEQT and VEQT?

All-in-one funds are the default holding for a huge number of Canadian investors, so it is worth spelling out what actually happens inside them. They get SpaceX through their US sleeve like everything else, just diluted twice over.

The first dilution is geographic. XEQT and VEQT are globally diversified, and US equities are only part of the mix, roughly 40-45% of each fund. So an illustrative SpaceX weight of about 0.13% inside the US total-market sleeve works out closer to 0.05-0.06% of the whole fund once you account for the Canadian, international, and emerging-market sleeves that hold none of it. In dollar terms that is roughly $5-$6 per $10,000, not $13.

The second dilution applies to the asset-allocation versions. XGRO and VGRO hold a bond sleeve alongside equities, and XBAL and VBAL hold more bonds still, so each step down the risk ladder shrinks the equity portion and the SpaceX sliver with it, from a few dollars in the growth funds to a dollar or two in the balanced ones.

There is also a timing detail worth knowing: the VEQT and XEQT methodologies created similar projected schedules. VEQT’s US sleeve tracks CRSP through VUN/VTI; XEQT’s tracks the S&P Total Market through ITOT. Both methodologies provide fast-entry routes, but this article treats the actual fund purchase dates as unconfirmed until supported by a dated holding.

The takeaway is not that all-in-ones are doing anything wrong. It is that the more diversified your single fund, the smaller and slower your SpaceX exposure, which is diversification working exactly as intended.

The CAGE exception

CAGE is the interesting outlier, because it is not a cap-weighted index tracker at all. It is an Avantis CIBC all-equity ETF that tilts toward value and profitability, screening for what it buys rather than holding everything an index hands it.

SpaceX at IPO is close to the opposite of what that screen rewards: expensive, unprofitable, and valued largely on growth, AI, and future optionality. A process built around value and profitability would likely exclude it or hold very little, at least until the fundamentals change.

That is not automatically better or worse than owning it. It is a different bet. A cap-weighted ETF takes whatever the market hands it, SpaceX included; a factor fund like CAGE deliberately passes on names that fail its screen. Which one you prefer depends on whether you want the whole market or a tilt away from exactly this kind of company, and this IPO is a clean illustration of that fork.

What this means for you

For most people, the honest answer is that you do not need to do anything. If you own the whole market through a broad index fund, a small SpaceX position is simply part of that bargain, the same way you already own hundreds of companies you have never thought about.

If you specifically do not want SpaceX exposure, the lever is your choice of index, not constant tinkering. Total-market and Nasdaq-100 funds are the most likely early buyers, S&P 500 funds are slower, and factor funds like CAGE may avoid it altogether. Pick the fund whose rules match what you want to own.

The one thing worth actually watching is the float, not the daily price. A small public float plus forced index demand is a setup for sharp moves in both directions, and because the staged unlocks expand the supply of shares throughout the year, both that supply and your fund’s position keep shifting. The first print is unlikely to be the fair price in either direction.

Frequently asked questions

When exactly will SpaceX be in my ETF?+

The confirmed benchmark event is Nasdaq-100 inclusion on July 7, 2026. The CRSP and S&P Total Market methodologies created projected fast-entry windows of roughly five trading or business days, but verify the actual VUN/VTI or ITOT/XUU holding on a dated fund disclosure. VFV and other S&P 500 funds are the slowest: S&P kept those rules unchanged, so any addition remains a 2027-or-later projection contingent on float, seasoning, profitability, and committee approval.

Did S&P change its rules to let SpaceX in?+

Partly. On June 4, 2026, S&P finalized its mega-cap consultation. It changed the S&P Total Market Index so a giant company with a tiny float can qualify through a market-cap test (a float-adjusted market cap of at least 10% of the 100th largest company) instead of the 10% float requirement, and it added an off-cycle IPO fast-track of about five business days, which is why SpaceX enters that index quickly. But it explicitly declined to change the S&P 500, S&P MidCap 400, or S&P SmallCap 600, saying market cap alone should not earn an exception to the financial viability, seasoning, and IWF requirements. So the broad Total Market path opened up while the S&P 500 path stayed shut.

Why is the position so small if SpaceX is worth $1.8 trillion?+

Because index funds generally weight by free float. The completed offering generated approximately $85.7 billion of gross proceeds, a far smaller investable-value proxy than the value of the whole company. The actual index float factor may differ, and future lockup releases can change it.

Does my SpaceX position stay the same after it is added?+

Not necessarily. The prospectus makes portions of the 180-day pool eligible for staged release and could take estimated free float toward roughly 44% by year end, while Musk’s stake remains locked longer. Eligibility to sell is not the same as an actual sale, and index providers make their own investable-weight decisions, so these remain projections.

Does this apply to Anthropic and OpenAI too?+

Broadly, yes. The exact timing and weight would depend on each company’s float, valuation, index eligibility, and the final index rules in force when they list.

Should I buy SpaceX directly at the IPO instead?+

That is a personal decision and beyond the scope of this article. The narrower point here is that you may get a small indirect position through index ETFs even if you never buy the stock directly.

I hold CAGE. Am I missing out?+

Maybe, maybe not. CAGE would likely avoid or underweight SpaceX because of its value and profitability process. That helps if the IPO disappoints and hurts if SpaceX performs well, which is the tradeoff you accept with any factor tilt.

---

This article is for educational purposes only and is not financial advice. Final offering price, trade date, closing shares, proceeds, and the July 7 Nasdaq-100 event are confirmed by the primary sources below. Index weights, fund purchase dates without a dated holding, future lockup releases, and any S&P 500 addition remain estimates or projections. Verify current fund holdings before making any decision.

Want to see where this kind of US-listed exposure best fits across your accounts? Try the Asset Location Optimizer to think through which of your registered and non-registered accounts should hold it.

Sources

• SpaceX IPO closing release, June 15, 2026
• SEC final offering terms: $135 price and June 12 trade date
• Nasdaq: SpaceX to join the Nasdaq-100 beginning July 7, 2026
• Space Exploration Technologies Corp. Form S-1/A, filed June 1, 2026
• Anthropic: confidential draft S-1 submission announcement, June 1, 2026
• CRSP Market Indexes: changes to float shares investability screen
• Nasdaq-100 Index methodology changes FAQ, May 2026
• S&P Dow Jones Indices consultation on treatment of MegaCap companies, April 30, 2026
• S&P Dow Jones Indices: Consultation on Treatment of MegaCap Companies — Results, June 4, 2026
• CNBC: SpaceX blocked from early U.S. benchmark index entry as S&P reaffirms existing rules, June 5, 2026
• FTSE Russell: IPO fast entry enhancements for Russell US Indexes
• CIBC fund snapshot: Avantis CIBC All-Equity Asset Allocation ETF